Quantcast

Latest Nootropics Stories

2014-09-09 20:21:42

LONDON, Sept. 9, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report: Lecithin & Phospholipids Market by Source (Soy, Sunflower, Egg, and Others), by Application (Food, Nutrition & Supplements, Cosmetics, Feed, Pharmaceuticals, and Others) - Global Trends & Forecasts to...

2014-08-27 23:05:06

The North America Lecithin Market report explains and analyzes the lecithin market in North America with analysis and projection of revenue. http://www.micromarketmonitor.com/market/north-america-lecithin-4958455009.html. (PRWEB) August 27, 2014 The North America Lecithin Market report explains and analyzes the lecithin market in North America with analysis and projection of revenue. The lecithin market in North America is estimated to grow from $233,542.9 million in 2012 to $325,926.6...

2014-08-20 23:03:50

The European Lecithin Market report explains and divides the lecithin market in Europe with analysis and projection of revenue. http://www.micromarketmonitor.com/market/europe-lecithin-4640857301.html (PRWEB) August 20, 2014 The European Lecithin Market report explains and divides the lecithin market in Europe with analysis and projection of revenue. The lecithin market in Europe is estimated to grow from $245, 078.3 million in 2012 to $317, 201.4 million by 2019, at a CAGR of 3.1%...

2014-08-19 23:04:01

The European Lecithin Market report explains and divides the lecithin market in Europe with analysis and projection of revenue. http://www.micromarketmonitor.com/market/europe-lecithin-4640857301.html (PRWEB) August 19, 2014 The European Lecithin Market report explains and divides the lecithin market in Europe with analysis and projection of revenue. The lecithin market in Europe is estimated to grow from $245,078.3 million in 2012 to $317,201.4 million by 2019, at a CAGR of 3.1% from...

shift work sleep and alertness aids
2014-08-14 03:30:14

The Cochrane Library Shift workers are taking drugs to help them stay awake or get to sleep despite weak evidence for their benefit, according to a new Cochrane review. The authors of the review found only small numbers of trials testing over-the-counter and prescription drugs used by shift workers, and the results suggest that for some people they might do more harm than good. In most developed countries, at least 10% of the workforce is involved in some form of shift work. European...

2014-07-17 16:25:39

LEXINGTON, Massachusetts, July 17, 2014 /PRNewswire/ -- Shire plc (LSE: SHP, NASDAQ: SHPG) today announced top-line results from two Phase 4 efficacy and safety studies of Vyvanse(R) (lisdexamfetamine dimesylate) compared with Concerta (methylphenidate HCl) with a placebo reference arm in adolescents aged 13-17 diagnosed with Attention-Deficit/Hyperactivity Disorder (ADHD). In SPD489-406, the forced-dose titration study, Vyvanse was found to be statistically superior to...

2014-07-14 23:02:13

The European Lecithin Market report explains and divides the Lecithin market in Europe with analysis and projection of revenue. The Lecithin Market in Europe is estimated to grow from around $241.7 million in 2012 to $315.9 million by 2019, at a CAGR of 3.2% from 2012 to 2019. http://www.micromarketmonitor.com/market/europe-lecithin-4640857301.html (PRWEB) July 14, 2014 The European Lecithin Market report explains and divides the Lecithin market in Europe with analysis and projection of...

2014-07-09 16:28:10

Study calls for more focus on long-term outcomes in pediatric trials of drugs intended for chronic use BOSTON, July 9, 2014 /PRNewswire-USNewswire/ -- Over the last 60 years, the U.S. Food and Drug Administration (FDA) approved 20 medications for attention deficit/hyperactivity disorder (ADHD) based on clinical trials that were not designed to study their long-term efficacy and safety or to detect rare adverse events, researchers at Boston Children's Hospital report today in PLOS...

2014-07-02 23:06:10

BCC Research (http://www.bccresearch.com) is pleased to announce the BCC Research Strattera® Forecast, a strategic investment product designed to provide market data for the pharmaceutical drug, Strattera®, a treatment for Attention Deficit Hyperactivity Disorder (ADHD) distributed by Eli Lilly and Company. Strattera® will lose its branded patent protection in late 2016 going into 2017, opening the market to distribution of generic treatments by competing companies....

2014-06-30 04:21:31

DUBLIN, June 30, 2014 /PRNewswire/ -- Shire plc ("Shire" or the "Company") (LSE: SHP, NASDAQ: SHPG) announces that its Canadian subsidiary(1) has received assessments from the Canadian revenue authorities, entitling it to total cash refunds equivalent to US$410 million(2). Following receipt of the assessments(3), the Company has recorded a net credit to income taxes amounting to US$216 million. This income tax credit will be excluded from Non GAAP income, and will not...


Word of the Day
out-herod
  • In the phrase to out-herod Herod, to be more violent than Herod (as represented in the old mystery plays); hence, to exceed in any excess of evil.
Herod refers to 'Herod the Great,' a Roman client king and 'a madman who murdered his own family and a great many rabbis.' According to the OED, the term is 'chiefly with allusion to Shakespeare's use' in Hamlet.
Related